{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:00:08Z","timestamp":1785499208175,"version":"3.56.0"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Tumor immunity is increasingly understood not only through the cellular composition of the tumor microenvironment, but also through spatially organized local niches that can help determine where immune recognition is initiated, constrained, suppressed, or therapeutically restored. This review develops an organ-conditioned and evidence-graded framework for tumor immunological niches as spatially localized, interaction-dependent, functionally consequential, and dynamically remodeled units. Rather than reproducing a general taxonomy of cancer immune niches, we focus on how shared niche-forming mechanisms are implemented differently by organ-specific tissue rules. We first distinguish the niche concept from broad tumor microenvironment descriptions, immune infiltration, immune compartments, and tertiary lymphoid structures. We then propose an operational evidence hierarchy that separates spatial association, recurrent interaction, functional consequence, perturbation-based validation, and therapeutic actionability. Next, we synthesize core mechanisms of niche formation, including tumor-intrinsic signaling, stromal and extracellular-matrix scaffolding, chemokine and cytokine wiring, vascular-hypoxic-metabolic boundaries, myeloid-centered suppression, and tissue-resident immune imprinting. Brain and lung tumors are treated as two organizing paradigms: immune-restricted niche architecture in the central nervous system and inflammation-primed niche architecture in the lung. Oral, liver, and pancreatic tumors are discussed comparatively to show how mucosal-microbial, tolerogenic-metabolic, and desmoplastic immune-exclusion rules reshape shared niche mechanisms. We further separate tumor-specific evidence, inflammatory analogies, and hypothesis-generating parallels to avoid overextending chronic inflammation or fibrosis models. Finally, we examine how niche architecture produces T-cell exclusion, antigen-presentation failure, suppressive myeloid-stromal feedback, and therapeutic resistance, and how release, access, and licensing strategies may guide organ-tailored combinations when supported by adequate evidence. This review argues that tumor immunological niches may serve as meso-level analytical units linking spatial organization, organ context, evidence strength, inflammatory parallels, and therapeutic vulnerability when their evidentiary status is explicitly defined.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1903920","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:29:54Z","timestamp":1785497394000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Formation and remodeling of immunological niches in solid tumors: organ-specific architectures, inflammatory parallels, and therapeutic reprogramming"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhuo","family":"Zhang","sequence":"first","affiliation":[{"name":"Sinopharm Dongfeng Stomatological Hospital, Affiliated Stomatological Hospital of Hubei University of Medicine","place":["Shiyan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Dong","sequence":"additional","affiliation":[{"name":"Sinopharm Dongfeng General Hospital (Hubei Clinical Research Center of Hypertension), Hubei University of Medicine","place":["Shiyan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchao","family":"Li","sequence":"additional","affiliation":[{"name":"Sinopharm Dongfeng Stomatological Hospital, Affiliated Stomatological Hospital of Hubei University of Medicine","place":["Shiyan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youling","family":"Shi","sequence":"additional","affiliation":[{"name":"Sinopharm Dongfeng Stomatological Hospital, Affiliated Stomatological Hospital of Hubei University of Medicine","place":["Shiyan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Mei","sequence":"additional","affiliation":[{"name":"Sinopharm Dongfeng General Hospital (Hubei Clinical Research Center of Hypertension), Hubei University of Medicine","place":["Shiyan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoxin","family":"Fu","sequence":"additional","affiliation":[{"name":"Sinopharm Dongfeng Stomatological Hospital, Affiliated Stomatological Hospital of Hubei University of Medicine","place":["Shiyan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01021-1","article-title":"Tumour and microenvironment crosstalk in NSCLC progression and response to therapy","volume":"22","author":"Rahal","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00909-2","article-title":"Linking macrophage metabolism to function in the tumor microenvironment","volume":"6","author":"Jin","year":"2025","journal-title":"Nat Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","article-title":"Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response","volume":"14","author":"Fu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.5mr0321-170r","article-title":"Tumor immunology in the age of single-cell genomics","volume":"110","author":"Zhao","year":"2021","journal-title":"J Leukocyte Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/00220345241271934","article-title":"Spatial transcriptomics unravel the tissue complexity of oral pathogenesis","volume":"103","author":"Haller","year":"2024","journal-title":"J Dent Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-022-01307-2","article-title":"Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors","volume":"15","author":"Xu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1675697","article-title":"Editorial: Formation of immunological niches in tumor microenvironments: mechanisms and therapeutic potential","volume":"15","author":"Chen","year":"2025","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1369626","article-title":"Tertiary lymphoid structures in cancer: maturation and induction","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.002","article-title":"High endothelial venules in cancer: regulation, function, and therapeutic implication","volume":"41","author":"Vella","year":"2023","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00706-z","article-title":"The roles of tertiary lymphoid structures in chronic diseases","volume":"19","author":"Sato","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02345-0","article-title":"Intratumoral dendritic cell-CD4(+) T helper cell niches enable CD8(+) T cell differentiation following PD-1 blockade in hepatocellular carcinoma","volume":"29","author":"Magen","year":"2023","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01792-2","article-title":"Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy","volume":"25","author":"Chen","year":"2024","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1158\/0008-5472.Can-23-2716","article-title":"LT\u03b2R agonism promotes antitumor immune responses via modulation of the tumor microenvironment","volume":"84","author":"An","year":"2024","journal-title":"Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c14753","article-title":"Reprogramming immunosuppressive niches and the cancer immunity cycle in pancreatic cancer with neoantigen mRNA plus immune adjuvant nanocarrier strategies","volume":"19","author":"Nel","year":"2025","journal-title":"ACS Nano"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01077-z","article-title":"The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities","volume":"22","author":"Kung","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.trecan.2023.06.010","article-title":"Perivascular niches: critical hubs in cancer evolution","volume":"9","author":"Nowosad","year":"2023","journal-title":"Trends Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12929-022-00879-y","article-title":"Spatial multi-omics analyses of the tumor immune microenvironment","volume":"29","author":"Hsieh","year":"2022","journal-title":"J BioMed Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41698-026-01314-3","article-title":"Graph neural network modeling of spatial tumor-immune interactions identifies prognostic cellular niches in non-small cell lung cancer","volume":"10","author":"Hoebel","year":"2026","journal-title":"NPJ Precis Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.08.039","article-title":"A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging","volume":"174","author":"Keren","year":"2018","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.07.005","article-title":"Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front","volume":"182","author":"Sch\u00fcrch","year":"2020","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-21-1714","article-title":"Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1123853","article-title":"Glioma-associated microglia\/macrophages (GAMs) in glioblastoma: immune function in the tumor microenvironment and implications for immunotherapy","volume":"14","author":"Lin","year":"2023","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02673-1","article-title":"Multiomic spatial landscape of innate immune cells at human central nervous system borders","volume":"30","author":"Sankowski","year":"2024","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1648601","article-title":"Harnessing innate immunity against glioblastoma microenvironment","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ijc.11708","article-title":"Inhaled particles and lung cancer. Part A: mechanisms","volume":"109","author":"Knaapen","year":"2004","journal-title":"Int J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052566","article-title":"The history and mystery of alveolar epithelial type II cells: focus on their physiologic and pathologic role in lung","volume":"22","author":"Ruaro","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00432-025-06373-w","article-title":"The role and mechanisms of the HIF-1 signaling pathway in LC-COPD","volume":"151","author":"Zheng","year":"2025","journal-title":"J Cancer Res Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.04.003","article-title":"Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101448","article-title":"An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005539","article-title":"Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer","volume":"11","author":"He","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-025-02287-w","article-title":"Single-cell and spatial transcriptomic analyses revealing tumor microenvironment remodeling after neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"24","author":"Cui","year":"2025","journal-title":"Mol Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032859","article-title":"Mechanisms contributing to the comorbidity of COPD and lung cancer","volume":"24","author":"Forder","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2147\/copd.S380732","article-title":"From COPD to lung cancer: mechanisms linking, diagnosis, treatment, and prognosis","volume":"17","author":"Qi","year":"2022","journal-title":"Int J Chronic Obstructive Pulmonary Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12931-024-02989-7","article-title":"SPP1 induces idiopathic pulmonary fibrosis and NSCLC progression via the PI3K\/Akt\/mTOR pathway","volume":"25","author":"Yue","year":"2024","journal-title":"Respir Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-082724-123843","article-title":"Immune niches in cancer","volume":"44","author":"Slingerland","year":"2026","journal-title":"Annu Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05680-3","article-title":"Single-cell spatial immune landscapes of primary and metastatic brain tumours","volume":"614","author":"Karimi","year":"2023","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081999","article-title":"Dissecting tumor-immune microenvironment in breast cancer at a spatial and multiplex resolution","volume":"14","author":"Tzoras","year":"2022","journal-title":"Cancers"},{"key":"B40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ccell.2025.12.009","article-title":"Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications","volume":"44","author":"Liu","year":"2026","journal-title":"Cancer Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218412","article-title":"CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030501","article-title":"The interplay between immunity and microbiota at intestinal immunological niche: the case of cancer","volume":"20","author":"Cianci","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115757","article-title":"Engineering tumor spatial heterogeneity in vitro","volume":"229","author":"Chen","year":"2026","journal-title":"Adv Drug Delivery Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41392-024-01955-5","article-title":"Multi-stage mechanisms of tumor metastasis and therapeutic strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1353787","article-title":"Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy","volume":"15","author":"Nicolini","year":"2024","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01932-0","article-title":"Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cas.15609","article-title":"The heterogeneity of cancer-associated fibroblast subpopulations: their origins, biomarkers, and roles in the tumor microenvironment","volume":"114","author":"Yamamoto","year":"2023","journal-title":"Cancer Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noag003","article-title":"Tumor microenvironment shapes the spatial organization of glioblastoma cell states","volume":"28","author":"Prakash","year":"2026","journal-title":"Neuro-Oncology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2023.2259096","article-title":"Exploring the tumor immune microenvironment in ovarian cancer: a way-out to the therapeutic roadmap","volume":"27","author":"Bhat","year":"2023","journal-title":"Expert Opin Ther Targets"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061899","article-title":"Cancer-associated fibroblasts: Master tumor microenvironment modifiers","volume":"15","author":"Wright","year":"2023","journal-title":"Cancers"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1472772","article-title":"Advances in targeting tumor microenvironment for immunotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70152","article-title":"STAT3 signaling pathway in health and disease","volume":"6","author":"Samad","year":"2025","journal-title":"MedComm"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108253","article-title":"Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options","volume":"237","author":"So","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120216","article-title":"Tumor-derived extracellular vesicles: The metastatic organotropism drivers","volume":"289","author":"Rezaie","year":"2022","journal-title":"Life Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00986-3","article-title":"The tumor microenvironment's role in the response to immune checkpoint blockade","volume":"6","author":"Aliazis","year":"2025","journal-title":"Nat Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.671595","article-title":"Cancer-associated fibroblast heterogeneity: A factor that cannot be ignored in immune microenvironment remodeling","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00740-4","article-title":"CAF-induced physical constraints controlling T cell state and localization in solid tumours","volume":"24","author":"Arpinati","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.7150\/thno.90627","article-title":"Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-\u03b2 activity and CD8(+) T-cell infiltration in breast cancer","volume":"14","author":"Honda","year":"2024","journal-title":"Theranostics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J Hepatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.7150\/thno.99046","article-title":"DAB2 (+) macrophages support FAP (+) fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer","volume":"14","author":"Long","year":"2024","journal-title":"Theranostics"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1515","article-title":"Single-cell and spatial transcriptomics reveal POSTN(+) cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer","volume":"13","author":"Chen","year":"2023","journal-title":"Clin Transl Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/cac2.12295","article-title":"Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy","volume":"42","author":"Bhat","year":"2022","journal-title":"Cancer Commun (London England)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1016\/j.cell.2024.10.006","article-title":"Ovarian cancer-derived IL-4 promotes immunotherapy resistance","volume":"187","author":"Mollaoglu","year":"2024","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06685-2","article-title":"IL-1\u03b2(+) macrophages fuel pathogenic inflammation in pancreatic cancer","volume":"623","author":"Caronni","year":"2023","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","article-title":"Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Nat Commun"},{"key":"B68","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1158\/0008-5472.Can-24-4916","article-title":"SPP1 drives colorectal cancer liver metastasis and immunotherapy resistance by stimulating CXCL12 production in cancer-associated fibroblasts","volume":"86","author":"Liu","year":"2026","journal-title":"Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.08.002","article-title":"Immunomodulation by endothelial cells: Prospects for cancer therapy","volume":"10","author":"Alnaqbi","year":"2024","journal-title":"Trends Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.09.044","article-title":"CXCL12(+) tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma","volume":"82","author":"Lu","year":"2025","journal-title":"J Hepatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2021.10.004","article-title":"Revisiting the HIF switch in the tumor and its immune microenvironment","volume":"8","author":"Cowman","year":"2022","journal-title":"Trends Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: Master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-022-01645-2","article-title":"The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: Mechanisms and clinical treatment strategies","volume":"21","author":"Bai","year":"2022","journal-title":"Mol Cancer"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13046-024-02994-0","article-title":"A glutamine tug-of-war between cancer and immune cells: Recent advances in unraveling the ongoing battle","volume":"43","author":"Wang","year":"2024","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00470-2","article-title":"Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer","volume":"3","author":"Cappellesso","year":"2022","journal-title":"Nat Cancer"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114686","article-title":"H3K9 lactylation in Malignant cells facilitates CD8(+) T cell dysfunction and poor immunotherapy response","volume":"43","author":"Wang","year":"2024","journal-title":"Cell Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1016\/j.cell.2025.10.030","article-title":"Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy","volume":"188","author":"von Locquenghien","year":"2025","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","article-title":"Spatiotemporal co-dependency between macrophages and exhausted CD8(+) T cells in cancer","volume":"40","author":"Kersten","year":"2022","journal-title":"Cancer Cell"},{"key":"B80","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","article-title":"Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity","volume":"55","author":"Hezaveh","year":"2022","journal-title":"Immunity"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","article-title":"Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108114","article-title":"Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy","volume":"235","author":"Joshi","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B83","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41586-023-06002-x","article-title":"Physiology and diseases of tissue-resident macrophages","volume":"618","author":"Lazarov","year":"2023","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03651-8","article-title":"Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells","volume":"595","author":"Casanova-Acebes","year":"2021","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2023.102984","article-title":"Tissue-resident macrophages - early passengers or drivers in the tumor niche","volume":"83","author":"Vogel","year":"2023","journal-title":"Curr Opin Biotechnol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1618700","article-title":"Keeping it local: How CD8 TRMs regulate viral and cancer immunity","volume":"16","author":"Rodrigues Junior","year":"2025","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01428-x","article-title":"Influenza-trained mucosal-resident alveolar macrophages confer long-term antitumor immunity in the lungs","volume":"24","author":"Wang","year":"2023","journal-title":"Nat Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215667","article-title":"CXCL10 conditions alveolar macrophages within the premetastatic niche to promote metastasis","volume":"537","author":"Shang","year":"2022","journal-title":"Cancer Lett"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115039","article-title":"IL-17A\/CEBP\u03b2\/OPN\/LYVE-1 axis inhibits anti-tumor immunity by promoting tumor-associated tissue-resident macrophages","volume":"43","author":"Zhao","year":"2024","journal-title":"Cell Rep"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061285","article-title":"The vascular microenvironment in glioblastoma: A comprehensive review","volume":"10","author":"Mosteiro","year":"2022","journal-title":"Biomedicines"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12772","article-title":"Tumour-associated CD204(+) microglia\/macrophages accumulate in perivascular and perinecrotic niches and correlate with an interleukin-6-enriched inflammatory profile in glioblastoma","volume":"48","author":"S\u00f8rensen","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13287","article-title":"Elucidating tumour-associated microglia\/macrophage diversity along glioblastoma progression and under ACOD1 deficiency","volume":"16","author":"Pires-Afonso","year":"2022","journal-title":"Mol Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13657","article-title":"Microglia and macrophages in glioblastoma: Landscapes and treatment directions","volume":"18","author":"Solomou","year":"2024","journal-title":"Mol Oncol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100872","article-title":"Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma","volume":"36","author":"Al-Holou","year":"2023","journal-title":"Neoplasia (New York NY)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-24-0743","article-title":"Mesenchymal stem cells and fibroblasts contribute to microvascular proliferation in glioblastoma and are correlated with immunosuppression and poor outcome","volume":"13","author":"Poon","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-21-1456","article-title":"ALKBH5 facilitates hypoxia-induced paraspeckle assembly and IL8 secretion to generate an immunosuppressive tumor microenvironment","volume":"81","author":"Dong","year":"2021","journal-title":"Cancer Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101238","article-title":"Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma","volume":"4","author":"Pang","year":"2023","journal-title":"Cell Rep Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","article-title":"Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41419-025-07819-2","article-title":"Transglutaminase 2 function in glioblastoma tumor efferocytosis","volume":"16","author":"Lui","year":"2025","journal-title":"Cell Death Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12967-025-06185-z","article-title":"Multi-transcriptomics reveals niche-specific expression programs and endothelial cells in glioblastoma","volume":"23","author":"Hu","year":"2025","journal-title":"J Transl Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add1016","article-title":"Multiomics and spatial mapping characterizes human CD8(+) T cell states in cancer","volume":"15","author":"Naulaerts","year":"2023","journal-title":"Sci Transl Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1158\/2159-8290.Cd-22-0455","article-title":"Targeting microglial metabolic rewiring synergizes with immune-checkpoint blockade therapy for glioblastoma","volume":"13","author":"Ye","year":"2023","journal-title":"Cancer Discov"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00620-0","article-title":"Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade","volume":"4","author":"Goswami","year":"2023","journal-title":"Nat Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaf099","article-title":"Multimodal glioma immunotherapy combining TLR9-targeted STAT3 antisense oligodeoxynucleotides with PD1 immune checkpoint blockade","volume":"27","author":"Hung","year":"2025","journal-title":"Neuro-Oncology"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-3382","article-title":"PP2Ac deficiency enhances tumor immunogenicity by activating STING-type I interferon signaling in glioblastoma","volume":"83","author":"Mondal","year":"2023","journal-title":"Cancer Res"},{"key":"B106","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1038\/s41467-025-60074-z","article-title":"Glioma-neuronal circuit remodeling induces regional immunosuppression","volume":"16","author":"Nejo","year":"2025","journal-title":"Nat Commun"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118253","article-title":"Mechanisms of pulmonary fibrosis and lung cancer induced by chronic PM(2.5) exposure: Focus on the airway epithelial barrier and epithelial-mesenchymal transition","volume":"297","author":"Shi","year":"2025","journal-title":"Ecotoxicology Environ Saf"},{"key":"B108","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s41232-024-00344-3","article-title":"Autocrine insulin-like growth factor 2 signaling as a potential target in the associated development of pulmonary emphysema and cancer in smokers","volume":"44","author":"Boo","year":"2024","journal-title":"Inflammation Regeneration"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2020.01.010","article-title":"Biomarkers for immunotherapy","volume":"30","author":"Bustamante-Alvarez","year":"2020","journal-title":"Thorac Surg Clinics"},{"key":"B110","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","article-title":"A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer","volume":"188","author":"Liu","year":"2025","journal-title":"Cell"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.ccell.2022.10.008","article-title":"High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer","volume":"40","author":"Salcher","year":"2022","journal-title":"Cancer Cell"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005531","article-title":"Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer","volume":"10","author":"Sun","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B113","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41368-021-00131-7","article-title":"Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma","volume":"13","author":"Elmusrati","year":"2021","journal-title":"Int J Oral Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1651837","article-title":"Microbiome-macrophage crosstalk in the tumor microenvironment: Implications for oral squamous cell carcinoma progression and therapy","volume":"16","author":"Deng","year":"2025","journal-title":"Front Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1186\/s12885-025-14261-2","article-title":"INHBA(+) macrophages and pro-inflammatory CAFs are associated with distinctive immunosuppressive tumor microenvironment in submucous fibrosis-derived oral squamous cell carcinoma","volume":"25","author":"Zhao","year":"2025","journal-title":"BMC Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adf4968","article-title":"Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer","volume":"8","author":"Oliveira","year":"2023","journal-title":"Sci Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: Pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cell.2020.08.040","article-title":"Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma","volume":"183","author":"Sharma","year":"2020","journal-title":"Cell"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ado3485","article-title":"Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma","volume":"10","author":"Liang","year":"2025","journal-title":"Sci Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101130","article-title":"Immunotherapy for hepatocellular carcinoma","volume":"6","author":"Childs","year":"2024","journal-title":"JHEP Reports: Innovation Hepatol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-22-0876","article-title":"Context-specific determinants of the immunosuppressive tumor microenvironment in pancreatic cancer","volume":"13","author":"Falcomat\u00e0","year":"2023","journal-title":"Cancer Discov"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116347","article-title":"Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma","volume":"44","author":"Korah","year":"2025","journal-title":"Cell Rep"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-20-0111","article-title":"Lactate-modulated immunosuppression of myeloid-derived suppressor cells contributes to the radioresistance of pancreatic cancer","volume":"8","author":"Yang","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.02.035","article-title":"IRAK4 signaling drives resistance to checkpoint immunotherapy in pancreatic ductal adenocarcinoma","volume":"162","author":"Somani","year":"2022","journal-title":"Gastroenterology"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1159\/000510979","article-title":"Oral microbiota and cancer development","volume":"88","author":"Tuominen","year":"2021","journal-title":"Pathobiology: J Immunopathology Mol Cell Biol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1572152","article-title":"Oral and intratumoral microbiota influence tumor immunity and patient survival","volume":"16","author":"Wei","year":"2025","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1038\/s41467-026-70861-x","article-title":"Spatial heterogeneity of MDSCs mediated by ANXA1-FPRs signaling drives immune suppression in OSCC progression","volume":"17","author":"Li","year":"2026","journal-title":"Nat Commun"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The role of cancer-associated fibroblasts and fibrosis in liver cancer","volume":"12","author":"Affo","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1186\/s12967-024-05613-w","article-title":"Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment","volume":"22","author":"Tong","year":"2024","journal-title":"J Transl Med"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.immuni.2025.05.006","article-title":"Efflux of N1-acetylspermidine from hepatoma fosters macrophage-mediated immune suppression to dampen immunotherapeutic efficacy","volume":"58","author":"Liu","year":"2025","journal-title":"Immunity"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217287","article-title":"Pirfenidone antagonizes TGF-\u03b21-mediated gabapentin resistance via reversal of desmoplasia and the 'cold' microenvironment in pancreatic cancer","volume":"605","author":"Zhang","year":"2024","journal-title":"Cancer Lett"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27093873","article-title":"Hypoxic tumor microenvironment targeting: Opportunities and challenges for pancreatic cancer immunotherapy","volume":"27","author":"Abou Khouzam","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0355-0","article-title":"A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling","volume":"30","author":"Qian","year":"2020","journal-title":"Cell Res"},{"key":"B134","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1038\/s41467-024-50478-8","article-title":"A single-cell pan-cancer analysis to show the variability of tumor-infiltrating myeloid cells in immune checkpoint blockade","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"key":"B135","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","article-title":"Tertiary lymphoid structures in cancer: Spatiotemporal heterogeneity, immune orchestration, and translational opportunities","volume":"18","author":"Deng","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303230","article-title":"Cancer-associated fibroblast-induced remodeling of tumor microenvironment in recurrent bladder cancer","volume":"10","author":"Liang","year":"2023","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.01.007","article-title":"From gatekeepers to providers: Regulation of immune functions by cancer-associated fibroblasts","volume":"9","author":"Arpinati","year":"2023","journal-title":"Trends Cancer"},{"key":"B138","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Sci (New York NY)"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202514661","article-title":"Spatial transcriptomics and snRNA-seq expose CAF niches orchestrating dual stromal-immune barriers in hepatocellular carcinoma","volume":"12","author":"Li","year":"2025","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1172\/jci183366","article-title":"Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy","volume":"134","author":"Song","year":"2024","journal-title":"J Clin Invest"},{"key":"B141","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-024-01618-6","article-title":"NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression","volume":"17","author":"Wang","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004874","article-title":"Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation","volume":"10","author":"Deng","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B143","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: Historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol Cancer"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Sci (New York NY)"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-02179-9","article-title":"Multi-dimensional omics integrated machine learning framework identifies macrophage-fibroblast-tumor co-infiltration patterns to predict prognosis in gastric cancer","volume":"9","author":"Wang","year":"2025","journal-title":"NPJ Digital Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-21-1804","article-title":"Cancer immunoediting in the era of immuno-oncology","volume":"28","author":"Gubin","year":"2022","journal-title":"Clin Cancer Research: Off J Am Assoc For Cancer Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02341-9","article-title":"Single-cell multi-omic and spatial profiling of esophageal squamous cell carcinoma reveals the immunosuppressive role of GPR116(+) pericytes in cancer metastasis","volume":"57","author":"Pei","year":"2025","journal-title":"Nat Genet"},{"key":"B148","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41423-025-01329-z","article-title":"PANoptosis in cancer: Bridging molecular mechanisms to therapeutic innovations","volume":"22","author":"Lin","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.cell.2025.12.042","article-title":"CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response","volume":"189","author":"Wang","year":"2026","journal-title":"Cell"},{"key":"B150","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-023-01462-z","article-title":"Radiation-induced tumor immune microenvironments and potential targets for combination therapy","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.7150\/thno.50928","article-title":"Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes","volume":"11","author":"Han","year":"2021","journal-title":"Theranostics"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-24-0932","article-title":"YAP1 inhibition induces phenotype switching of cancer-associated fibroblasts to tumor suppressive in prostate cancer","volume":"84","author":"Song","year":"2024","journal-title":"Cancer Res"},{"key":"B153","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2025.2569934","article-title":"Does a link exist between oral microbiota and oral squamous cell carcinoma? A review of current insights","volume":"17","author":"Santacroce","year":"2025","journal-title":"J Oral Microbiol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3390\/cells13201726","article-title":"Hepatocellular-carcinoma-derived organoids: innovation in cancer research","volume":"13","author":"Airola","year":"2024","journal-title":"Cells"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1903920\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:29:56Z","timestamp":1785497396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1903920\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":155,"alternative-id":["10.3389\/fimmu.2026.1903920"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1903920","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"1903920"}}